US Patent 7592357 Compounds
Patent 7592357 was granted and assigned to Smithkline Beecham Limited on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+61 characters)
Article
Patent abstract
Novel Inhibitors of Rho-kinases are disclosed.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07592357 Compounds US Patent 7592357 Compounds
Infobox
Patent Number
0759235700
Patent Number
759235700
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075923570
Date of Patent
September 22, 2009
0Patent Application Number
105899950
Date Filed
February 18, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075923570
Date of Patent
September 22, 2009
0Patent Application Number
105899950
Date Filed
February 18, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07592357 Compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07592357
Date of patent
September 22, 2009
Patent application number
10589995
Date Filed
February 18, 2005
Patent primary examiner
Find more entities like US Patent 7592357 Compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
